Holen Sie sich die Stockscreener-App
0.691
4.68%
0.0309
Handel nachbörslich:
.68
-0.011
-1.59%
Schlusskurs vom Vortag:
$0.6601
Offen:
$0.6651
24-Stunden-Volumen:
69,927
Relative Volume:
0.42
Marktkapitalisierung:
$6.09M
Einnahmen:
$453.30K
Nettoeinkommen (Verlust:
$-1.03M
KGV:
-6.1042
EPS:
-0.1132
Netto-Cashflow:
-
1W Leistung:
+19.14%
1M Leistung:
-79.75%
6M Leistung:
-85.96%
1J Leistung:
-91.36%
1-Tages-Spanne:
$0.6521
$0.717
1-Wochen-Bereich:
$0.5301
$0.72
52-Wochen-Spanne:
$0.5301
$10.28
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
Firmenname
X T L Biopharmaceuticals Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XTLB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XTLB
X T L Biopharmaceuticals Ltd Adr
|
0.691 | 5.82M | 453.30K | -1.03M | 0 | -0.1132 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2015-05-08 | Eingeleitet | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr Aktie (XTLB) Neueste Nachrichten
XTL Biopharmaceuticals Takes Major Impairment on The Social Proxy in First-Half 2025 Results - The Globe and Mail
XTL Biopharmaceuticals takes major impairment on the Social Proxy in first-half 2025 results - MSN
XTL Biopharmaceuticals Faces Nasdaq Bid-Price Deficiency, Given Until June 2026 to Regain Compliance - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
XTL Biopharmaceuticals Faces Leadership Changes at Social Proxy Subsidiary - The Globe and Mail
XTL Biopharmaceuticals Announces CFO Transition Amid Strategic Appointments - The Globe and Mail
Total debt per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A2DK34 - TradingView
Changes in working capital of XTL Biopharmaceuticals Ltd. Sponsored ADR – FWB:H2K2 - TradingView
XTL Biopharmaceuticals Announces Board Changes Following Resignation - MSN
Nothing is Better Than Stitch Fix Inc (SFIX) stock at the moment - Setenews
XTL Biopharmaceuticals Approves Key Resolutions at Shareholder Meeting - TipRanks
XTL Biopharmaceuticals Postpones Shareholders’ Meeting Due to Quorum Issue - TipRanks
XTL Biopharmaceuticals Enters Sublicense Agreement with Biossil - TipRanks
XTL Biopharmaceuticals Reports Financial Results Amid Regional Unrest - TipRanks
XTL Biopharmaceuticals Expands with AI Company Acquisition - TipRanks
XTL Biopharmaceuticals Confirms Board and Auditor Appointments - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - Investing.com India
XTLB Stock Price and Chart — NASDAQ:XTLB - TradingView
XTL Biopharmaceuticals Ltd Share Price ADR Each Repr 100 Shs Spon - Hargreaves Lansdown
XTLB Financial Statements & ChartsX.t.l. Biopharmaceuticals Ltd.Adr MacroTrends - CMLviz
XTLB Pivot Points, Technical Analysis and Moving AveragesX.t.l. Biopharmaceuticals Ltd.Adr Technicals - CMLviz
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates - Yahoo Finance
List of US Companies Releasing Earnings (EPS) Today - FXLeaders
The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher - Benzinga
XTLB Stock Price and Chart — TASE:XTLB - TradingView — Track All Markets
XTLB Stock Price | XTL Biopharmaceuticals Ltd. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch
Check out X T L Biopharmaceuticals Ltd's stock price (XTLB) in real time - CNBC
XTLBX.T.L. Biopharmaceuticals Ltd. ADR Stock Price and Quote - Finviz
INGN Stock Price | Inogen Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
Finanzdaten der X T L Biopharmaceuticals Ltd Adr-Aktie (XTLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):